3.88 USD
↗ 0.15 (4.02%)LIVE (AS OF 01:02 PM EDT)
Impact BioMedical, Inc. (IBO) trades at $3.88 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 26, 2026.
Open?$3.78
High?$4.20
Low?$3.48
Prev. Close?$3.73
Volume?9.5K
Avg. Volume?42.6K
VWAP?$4.05
Rel. Volume?0.22x
Bid / Ask
Bid?$3.74 × 100
Ask?$4.02 × 100
Spread?$0.28
Midpoint?$3.88
Valuation & Ratios
Market Cap?31.9M
Shares Out?8.5M
Float?11.7M
Float %?10.9%
P/E Ratio?40.39
P/B Ratio?2.96
EPS?$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Employees
8
Market Cap
30.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?20
Momentum?71
Short Sent.?69
Piotroski F-Score?0/9Weak
Altman Z-Score?1.48Distress
Confidence?44%Low
Short InterestLow
Short % of Float?0.22%Low
Short Interest?26.3K
Days to Cover?2.1
Free Float11.7M
Avg Daily Volume12.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.13Weak
Cash Ratio?0.00Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score60/100
P/E?40.4PRICEY▾
Peers100
S&P18
P/B?2.96CHEAP▾
Peers100
S&P56
P/S?910.51HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.1CHEAP▾
S&P97
EV/Sales?910.23HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?7.3%FAIR▾
Peers50
S&P24
ROA?4.7%FAIR▾
Peers50
S&P43
Cash Flow & Enterprise
FCF?$-508000
Enterprise Value?$31.9M
Fundamentals ratios updated end of day